NRIP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.059200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.693200E-01
Normal-vs-Stage2
2.824000E-01
Normal-vs-Stage3
4.123800E-01
Normal-vs-Stage4
1.437400E-01
Stage1-vs-Stage2
3.325200E-01
Stage1-vs-Stage3
5.196800E-01
Stage1-vs-Stage4
1.776970E-01
Stage2-vs-Stage3
9.023800E-01
Stage2-vs-Stage4
6.413400E-01
Stage3-vs-Stage4
6.597600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.142800E-01
Normal-vs-AfricanAmerican
2.293800E-01
Normal-vs-Asian
2.675800E-01
Caucasian-vs-AfricanAmerican
9.259200E-01
Caucasian-vs-Asian
2.774800E-01
AfricanAmerican-vs-Asian
4.618600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.033600E-01
Normal-vs-Female
3.073800E-01
Male-vs-Female
7.748000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.801400E-01
Normal-vs-Age(41-60Yrs)
2.423600E-01
Normal-vs-Age(61-80Yrs)
3.335600E-01
Normal-vs-Age(81-100Yrs)
3.616800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.907800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.464800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.756600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.787240E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.646000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.982400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.081000E-01
Normal-vs-Daily Drinker
4.042800E-01
Normal-vs-Weekly Drinker
1.957550E-01
Normal-vs-Occasional Drinker
3.037800E-01
Normal-vs-Social Drinker
3.331600E-01
Non Drinker-vs-Daily Drinker
4.651000E-01
Non Drinker-vs-Weekly Drinker
2.408200E-02
Non Drinker-vs-Occasional Drinker
8.228500E-02
Non Drinker-vs-Social Drinker
1.362370E-01
Daily Drinker-vs-Weekly Drinker
4.068200E-02
Daily Drinker-vs-Occasional Drinker
1.865580E-01
Daily Drinker-vs-Social Drinker
2.631600E-01
Weekly Drinker-vs-Occasional Drinker
2.046800E-01
Weekly Drinker-vs-Social Drinker
2.117800E-01
Occasional Drinker-vs-Social Drinker
9.350800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.807000E-01
Normal-vs-Grade 2
6.485800E-01
Normal-vs-Grade 3
6.391400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.441100E-03
Grade 1-vs-Grade 3
3.494400E-02
Grade 1-vs-Grade 4
5.807000E-01
Grade 2-vs-Grade 3
6.792800E-01
Grade 2-vs-Grade 4
6.485800E-01
Grade 3-vs-Grade 4
6.391400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.593000E-01
Normal-vs-NonDiabetic
3.594800E-01
Diabetic-vs-NonDiabetic
8.676800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.107600E-01
Normal-vs-NoPancreatitis
3.798600E-01
Pancreatitis-vs-NoPancreatitis
2.860200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.118600E-01
Normal-vs-N1
2.687200E-01
N0-vs-N1
1.453980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.300400E-01
Normal-vs-TP53-NonMutant
6.470800E-01
TP53-Mutant-vs-TP53-NonMutant
2.658700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
